Inventor · disambiguated record
Jean-Laurent Paparin
Also filed as: PAPARIN JEAN-LAURENT
14 granted patents·10 pending applications·164 citations·filing 2006–2022
90Inventor score
Files withMERCK SHARP & DOHME5IDENIX PHARMACEUTICALS INC4ENYO PHARMA3IDENIX PHARMACEUTICALS LLC3ADDEX PHARMACEUTICALS SA2
Top patents by PatentIndex Score
24 records- 0195US8362068B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·66 cites·53 claims
- 0294US7932240B2Phosphadiazine HCV polymerase inhibitors IVIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Apr 26, 2011·39 cites·61 claims
- 0390US10519159B2Antiviral aliphatic ester prodrugs of tenofovirMERCK SHARP & DOHME·Filed 2017·Granted Dec 31, 2019·5 cites·22 claims
- 0490US8193372B2Phosphothiophene and phosphothiazole HCV polymerase inhibitorsDOUSSON CYRIL·Filed 2010·Granted Jun 5, 2012·37 cites·29 claims
- 0585US10449208B2Antiviral prodrugs of tenofovirMERCK SHARP & DOHME·Filed 2017·Granted Oct 22, 2019·3 cites·18 claims
- 0684US9187496B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·8 cites·45 claims
- 0783US10815264B2Nucleotides for the treatment of cancerIDENIX PHARMACEUTICALS LLC·Filed 2016·Granted Oct 27, 2020·2 cites·10 claims
- 0880US10202411B23′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Feb 12, 2019·3 cites·29 claims
- 0976US10745428B2Antiviral phosphodiamide prodrugs of tenofovirMERCK SHARP & DOHME·Filed 2016·Granted Aug 18, 2020·1 cites·4 claims
- 1060US11603368B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Mar 14, 2023·0 cites·2 claims
- 1158US11767316B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Sep 26, 2023·0 cites·9 claims
- 1255US2017198005A12'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infectionIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1355US2024262833A1Fused heterocyclic derivatives as negative allosteric modulators of mglu7 receptorADDEX PHARMACEUTICALS SA·Filed 2022·Application pending·0 cites
- 1454US2016229866A1Hepatitis c virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1553US2024327375A1Substituted heterobicyclic derivatives as negative allosteric modulators of mglu7 receptorADDEX PHARMACEUTICALS SA·Filed 2022·Application pending·0 cites
- 1650US2008103159A1Composition Comprising OcaperidoneKHANNA SATISH·Filed 2006·Application pending·0 cites
- 1748US2023150978A1Quinazolinone derivatives and uses thereof for treating a cancerENYO PHARMA·Filed 2021·Application pending·0 cites
- 1846US12173026B2PRMT5 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Dec 24, 2024·0 cites·20 claims
- 1946US2012009266A1Composition comprising ocaperidoneKHANNA SATISH·Filed 2011·Application pending·0 cites
- 2045US11123355B2Antiviral benzyl-amine phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2017·Granted Sep 21, 2021·0 cites·20 claims
- 2142US2008200479A1Ocaperidone Salts and Pharmaceutical Compositions Containing the SameBIONDI STEFANO·Filed 2006·Application pending·0 cites
- 2240US10736908B2Antiviral aryl-amide phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2017·Granted Aug 11, 2020·0 cites·14 claims
- 2338US2012252721A1Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitorDOUSSON CYRIL B·Filed 2012·Application pending·0 cites
- 2431US2017101431A1Nucleoside derivatives for the treatment of cancerDOUSSON CYRIL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Laurent Paparin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →